Answers are grounded in this paper and cite their sources.
The dose adjusted subcutaneous testosterone enanthate auto-injector demonstrated a steady serum total testosterone pharmacokinetic profile with small peak and trough fluctuations. The device was safe, well tolerated and virtually painless, indicating that this subcutaneous testosterone enanthate auto-injector offers a testosterone delivery system that is a convenient weekly option to treat testosterone deficiency.
No takes yet. Share an insight, caveat, or question.
Kaminetsky et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: